Pillstats
Rx only · Tablet, Extended Release · Oral

Guanfacine

Brands: Intuniv · Guanfacine Hydrochloride

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US83 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC02AC02
RxCUI (US)40114
US makers18 labelers
Packages137
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 39 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.340$0.681$1.02$1.36Dec 2025Apr 2026Jul 2026
$1.106
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
18
Active US suppliers
26%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

419K838K1.3M1.7M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.4M
Rx · 2026 Q1
47.6M
Units dispensed
-1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown20SUPPLYING
Advagen Pharma Ltdunknown16SUPPLYING
Alembic Pharmaceuticals Limitedunknown16SUPPLYING
Bryant Ranch Prepackrepackager12SUPPLYING
Upsher-Smith Laboratories, LLCunknown12SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown11SUPPLYING
Golden State Medical Supply, Inc.unknown8SUPPLYING
REMEDYREPACK INC.repackager6SUPPLYING
Actavis Pharma, Inc.unknown4SUPPLYING
Takeda Pharmaceuticals America, Inc.unknown4SUPPLYING
NorthStar RxLLCunknown4SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown4SUPPLYING
Fosun Pharma USA Incunknown4SUPPLYING
Slate Run Pharmaceuticals, LLCunknown4SUPPLYING
AvKAREunknown4SUPPLYING

+ 3 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 13, 2025
    RESOLVEDShortage resolved: Guanfacine Hydrochloride Tablet, Extended Release (Actavis Pharma, Inc.)

    Guanfacine Hydrochloride Tablet, Extended Release — reported in shortage by Actavis Pharma, Inc.. Therapeutic category: Psychiatry.

  • Nov 13, 2025
    SHORTAGEDrug shortage: Guanfacine Hydrochloride Tablet, Extended Release (Actavis Pharma, Inc.)

    Guanfacine Hydrochloride Tablet, Extended Release — reported in shortage by Actavis Pharma, Inc.. Therapeutic category: Psychiatry.

  • Mar 31, 2021
    RECALLRecall (Class II): Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Cana…

    Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate — Recalling firm: Apotex Corp. — Nationwide within the United States